Global AMR Governance

Global AMR governance focuses on the coordinated international systems, policies, and regulatory mechanisms designed to control antimicrobial resistance across healthcare, veterinary, and environmental sectors. This session examines how fragmented antibiotic regulation across countries contributes to the spread of resistant pathogens and why unified global action is essential to preserve antimicrobial effectiveness. At the Infection Conference, experts will evaluate how international cooperation is reshaping resistance control strategies at a systemic level.

Antimicrobial resistance emerges when microorganisms adapt and survive exposure to drugs that were previously effective against them. This evolution is accelerated by inappropriate antibiotic prescribing, overuse in agriculture, incomplete treatment courses, and weak regulatory enforcement. As resistant strains spread across borders through travel, trade, and migration, isolated national responses become insufficient to contain the problem.

Strengthening governance requires alignment of surveillance infrastructures, regulatory enforcement mechanisms, and stewardship practices across countries with varying healthcare capacities. Differences in diagnostic access, reporting transparency, and antibiotic control policies create gaps that allow resistant organisms to persist and expand globally. Addressing these disparities requires not only technical solutions but also sustained political and financial commitment.

A unified regulatory structure, Global Resistance Governance, represents coordinated international frameworks that align antibiotic usage regulations, resistance monitoring standards, and cross-border reporting systems to ensure consistent governance of antimicrobial use and containment of resistant pathogens across interconnected health systems.

Modern governance approaches are moving beyond isolated national policies toward integrated global accountability models, where human health systems, veterinary practices, and environmental monitoring are jointly regulated to maintain long-term antimicrobial effectiveness and reduce the emergence of drug-resistant infections worldwide.